Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Theratechnologies ( (TSE:TH) ) has issued an announcement.
Theratechnologies has resumed the distribution of EGRIFTA SV® after receiving clearance from the FDA to release two new batches. This move ensures the availability of the treatment for people with HIV in the United States, with the FDA’s review of the Prior Approval Supplement continuing and expected to conclude by April 18, 2025.
More about Theratechnologies
Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that aim to redefine standards of care.
YTD Price Performance: -11.96%
Average Trading Volume: 109,427
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $74.98M
Learn more about TH stock on TipRanks’ Stock Analysis page.
